ZANCAN, VALERIA
ZANCAN, VALERIA
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
Clinical and immunological impact of ocrelizumab extended interval dosing in multiple sclerosis: a single-center, real-world experience
2024 Nasello, Martina; Zancan, Valeria; Rinaldi, Virginia; Marrone, Antonio; Reniè, Roberta; Diamant, Selene; Marconi, Martina; Le Mura, Lorenzo; Salvetti, Marco; Buscarinu, Maria Chiara; Bellucci, Gianmarco
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
2022 Rinaldi, Virginia; Bellucci, Gianmarco; Buscarinu, Maria Chiara; Reniè, Roberta; Marrone, Antonio; Nasello, Martina; Zancan, Valeria; Nistri, Riccardo; Palumbo, Roberto; Salerno, Antonio; Salvetti, Marco; Ristori, Giovanni
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report
2024 Nasello, Martina; Zancan, Valeria; Reniè, Roberta; Romano, Silvia; Buscarinu, Maria Chiara; Ristori, Giovanni; Salvetti, Marco; Bellucci, Gianmarco
Gut microbiota composition is causally linked to multiple sclerosis: a mendelian randomization analysis
2024 Zancan, Valeria; Nasello, Martina; Bigi, Rachele; Reniè, Roberta; Buscarinu, Maria Chiara; Mechelli, Rosella; Ristori, Giovanni; Salvetti, Marco; Bellucci, Gianmarco
Influence of oral and skin microbiota on multiple sclerosis risk and severity: A mendelian randomization analysis
2025 Zancan, Valeria; Nasello, Martina; Diamant, Selene; Marconi, Martina; Bigi, Rachele; Reniè, Roberta; Buscarinu, Maria Chiara; Mechelli, Rosella; Ristori, Giovanni; Salvetti, Marco; Bellucci, Gianmarco
Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance project
2025 Ragonese, Paolo; Buscarinu, Maria Chiara; Cellerino, Maria; Colombo, Elena; Frau, Jessica; Frigo, Maura; Puthenparampil, Marco; Rigoni, Eleonora; Zancan, Valeria; Pinto, Luca; Parretti, Simone; Gazzaniga, Letizia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical and immunological impact of ocrelizumab extended interval dosing in multiple sclerosis: a single-center, real-world experience | 2024 | Nasello, Martina; Zancan, Valeria; Rinaldi, Virginia; Marrone, Antonio; Reniè, Roberta; Diamant, Selene; Marconi, Martina; Le Mura, Lorenzo; Salvetti, Marco; Buscarinu, Maria Chiara; Bellucci, Gianmarco | |
| CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review | 2022 | Rinaldi, Virginia; Bellucci, Gianmarco; Buscarinu, Maria Chiara; Reniè, Roberta; Marrone, Antonio; Nasello, Martina; Zancan, Valeria; Nistri, Riccardo; Palumbo, Roberto; Salerno, Antonio; Salvetti, Marco; Ristori, Giovanni | |
| Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report | 2024 | Nasello, Martina; Zancan, Valeria; Reniè, Roberta; Romano, Silvia; Buscarinu, Maria Chiara; Ristori, Giovanni; Salvetti, Marco; Bellucci, Gianmarco | |
| Gut microbiota composition is causally linked to multiple sclerosis: a mendelian randomization analysis | 2024 | Zancan, Valeria; Nasello, Martina; Bigi, Rachele; Reniè, Roberta; Buscarinu, Maria Chiara; Mechelli, Rosella; Ristori, Giovanni; Salvetti, Marco; Bellucci, Gianmarco | |
| Influence of oral and skin microbiota on multiple sclerosis risk and severity: A mendelian randomization analysis | 2025 | Zancan, Valeria; Nasello, Martina; Diamant, Selene; Marconi, Martina; Bigi, Rachele; Reniè, Roberta; Buscarinu, Maria Chiara; Mechelli, Rosella; Ristori, Giovanni; Salvetti, Marco; Bellucci, Gianmarco | |
| Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance project | 2025 | Ragonese, Paolo; Buscarinu, Maria Chiara; Cellerino, Maria; Colombo, Elena; Frau, Jessica; Frigo, Maura; Puthenparampil, Marco; Rigoni, Eleonora; Zancan, Valeria; Pinto, Luca; Parretti, Simone; Gazzaniga, Letizia |